-
12601“…BACKGROUND: Because of shared modes of transmission, patients with hepatitis C virus (HCV) infection are often co-infected with other types of hepatitis viruses and/or HIV. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12602“…Previous history of IV/IM injections, spouse patient of hepatitis, blood transfusion, surgical operation were found significant risk factors in the transmission of both hepatitis B and C, while previous history of dental treatment and sharing of clippers were significant risk factor in spreading hepatitis C infection only. CONCLUSIONS: Overall prevalence of HCV was higher than HBV. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12603por Tanaka, Yoshimasa, Iwasaki, Masashi, Murata-Hirai, Kaoru, Matsumoto, Kenji, Hayashi, Kosuke, Okamura, Haruki, Sugie, Tomoharu, Minato, Nagahiro, Morita, Craig T., Toi, Masakazu“…The development of phosphate and phosphonate nucleotide prodrugs has led to important drugs for hepatitis C and HIV. Using a similar approach, we synthesized bisphosphonate prodrugs and found that they efficiently limit tumor cell growth. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12604por Niriella, Madunil Anuk, Kobbegala, Vipuli Jayendra, Karalliyadda, Hasnatha Nuwan, Ranawaka, Chamila Kumara, de Silva, Arjuna Priyadarshin, Dassanayake, Anuradha Supun, de Silva, Hithanadura Janaka“…Most patients had either cryptogenic cirrhosis (62.6%) or alcoholic cirrhosis (29.9%); 2 (1.9%) had HBV cirrhosis, none had hepatitis C (HCV) cirrhosis. None of the patients had received vaccination against hepatitis A, while 71 (67.6%) had been vaccinated against HBV. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12605por Baibhav, Bipul, Mahabir, Chetaj A., Xie, Feng, Shostrom, Valerie K., McCashland, Timothy M., Porter, Thomas R.“…The main causes of liver failure were hepatitis C (25%) and nonalcoholic fatty liver disease (13%). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12606por Haug, Nancy A., Kieschnick, Dustin, Sottile, James E., Babson, Kimberly A., Vandrey, Ryan, Bonn-Miller, Marcel O.“…In terms of cannabinoid concentrations, dispensary staff were most likely to recommend a 1:1 ratio of delta-9-tetrahydrocannabinol (THC):cannabidiol (CBD) for patients suffering from anxiety, Crohn's disease, hepatitis C, and PTSD/trauma, while patients seeking appetite stimulation were most likely to be recommended THC. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12607por Russelli, Giovanna, Pizzillo, Paola, Iannolo, Gioacchin, Barbera, Floriana, Tuzzolino, Fabio, Liotta, Rosa, Traina, Mario, Vizzini, Giovanni, Gridelli, Bruno, Badami, Ester, Conaldi, Pier Giulio“…PURPOSE: Hepatitis C virus (HCV) predominantly infects hepatocytes, although it is known that receptors for viral entry are distributed on a wide array of target cells. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12608por Lin, Jihui, Wang, Chengbao, Zhang, Longxiang, Wang, Tao, Zhang, Jing, Liang, Wulong, Li, Cheng, Qian, Gui, Ouyang, Yueling, Guo, Kangkang, Zhang, Yanming“…Rab5, a member of the small Rab GTPase family, is involved in infection and replication of numerous viruses including hepatitis C virus and dengue virus. Until now, the effects of Rab5 on the proliferation of CSFV are poorly defined. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12609por Ribeiro Barbosa, Jakeline, Sousa Bezerra, Cristianne, Carvalho-Costa, Filipe Anibal, Pimentel de Azevedo, Carolina, Lopes Flores, Geane, Baima Colares, Jeová Keny, Malta Lima, Danielle, Lampe, Elisabeth, Melo Villar, Lívia“…Background: HBV (Hepatitis B Virus) and HCV (Hepatitis C Virus) infections are more prevalent in vulnerable populations than the general population. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12610por Bazerbachi, Fateh, Leise, Michael D., Watt, Kymberly D., Murad, M. Hassan, Prokop, Larry J., Haffar, Samir“…Background and aim: Mixed cryoglobulinemia (MC) has been associated with several viral infections, and chronic hepatitis C is recognized as a major cause. MC associated with hepatitis E virus (HEV) has been described and little is known about this rare association. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12611por Bagchi, Shashwatee, Burrowes, Shana AB, Fantry, Lori E, Hossain, Mian B, Tollera, Gemechis H, Kottilil, Shyamasundaran, Pauza, C David, Miller, Michael, Baumgarten, Mona, Redfield, Robert R“…The medical co-morbidities associated with increased atherosclerotic vascular disease risk were hepatitis C infection (X(2) = 3.93; p value = 0.048), elevated triglycerides levels (X(2) = 4.0; p value = 0.046), and low albumin (X(2) = 4.65; p value = 0.031). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12612por Donaires, Flávia S., Scatena, Natália F., Alves-Paiva, Raquel M., Podlevsky, Joshua D., Logeswaran, Dhenugen, Santana, Barbara A., Teixeira, Andreza C., Chen, Julian J.-L., Calado, Rodrigo T., Martinelli, Ana L. C.“…A novel TERT variant, A243V, was identified in a 65-year-old male with advanced HCC and cirrhosis secondary to chronic hepatitis C virus (HCV) and alcohol ingestion, but direct assay measurements in vitro did not detect modulation of telomerase enzymatic activity or processivity. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12613por Karlsson, Niklas, Santacatterina, Michele, Käll, Kerstin, Hägerstrand, Maria, Wallin, Susanne, Berglund, Torsten, Ekström, Anna Mia“…CONCLUSIONS: Women, early drug debut, amphetamine users and homeless people had a significantly higher level of injection risk behaviour and need special attention and tailored prevention to successfully combat hepatitis C and HIV transmission among PWID. TRIAL REGISTRATION: ClinicalTrials.gov Identifier, NCT02234167…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12614por Saber, Mohamed A, AbdelHafiz, Samah MM, Khorshed, Fatma E, Aboushousha, Tarek S, Hamdy, Hussam EM, Seleem, Mohamed I, Soliman, Amira H“…The objective of this study was to evaluate the differential expression of GPC-3 and IGF-II mRNAs in HCC tissues with a background of chronic hepatitis C virus (HCV) genotype 4 cirrhosis, in relation to Ki-67 and alpha-feto protein (AFP) tissue markers. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12615por Paemanee, Atchara, Sornjai, Wannapa, Kittisenachai, Suthathip, Sirinonthanawech, Naraporn, Roytrakul, Sittiruk, Wongtrakul, Jeerang, Smith, Duncan R.“…Hepatotoxicity is one of the most severe adverse effects, particularly in HIV patients with chronic hepatitis C virus co-infection as these patients can develop liver toxicity after a relatively short course of treatment. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12616por Aydin, Yucel, Chedid, Milad, Chava, Srinivas, Danielle Williams, Donkita, Liu, Shuanghu, Hagedorn, Curt H., Sumitran-Holgersson, Suchitra, Reiss, Krzysztof, Moroz, Krzysztof, Lu, Hua, Balart, Luis A., Dash, Srikanta“…The mechanism of how chronic hepatitis C virus (HCV) infection leads to such a high rate of hepatocellular carcinoma (HCC) is unknown. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12617por Stokkeland, Knut, Ludvigsson, Jonas Filip, Hultcrantz, Rolf, Ekbom, Anders, Höijer, Jonas, Bottai, Matteo, Stephansson, Olof“…Previous studies have shown inconsistent results with respect to hepatitis B (HBV), hepatitis C (HCV) and pregnancy outcome. The aim of this study was to investigate pregnancy outcome in women with HBV or HCV. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12618por Ferreira, André C., Zaverucha-do-Valle, Camila, Reis, Patrícia A., Barbosa-Lima, Giselle, Vieira, Yasmine Rangel, Mattos, Mayara, Silva, Priscila de Paiva, Sacramento, Carolina, de Castro Faria Neto, Hugo C., Campanati, Loraine, Tanuri, Amilcar, Brüning, Karin, Bozza, Fernando A., Bozza, Patrícia T., Souza, Thiago Moreno L.“…Sofosbuvir, a drug in clinical use against hepatitis C virus (HCV), is among the FDA-approved substances endowed with anti-ZIKV activity. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12619por Bartolini, Barbara, Giombini, Emanuela, Taibi, Chiara, Lionetti, Raffaella, Montalbano, Marzia, Visco-Comandini, Ubaldo, D’Offizi, Gianpiero, Capobianchi, Maria Rosaria, McPhee, Fiona, Garbuglia, Anna Rosa“…Hepatitis C virus (HCV) genotype (GT)3 is associated with increased risk of steatosis, development of cirrhosis and hepatocellular carcinoma. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12620por Duffy, Darragh, Mottez, Estelle, Ainsworth, Shaun, Buivan, Tan-Phuc, Baudin, Aurelie, Vray, Muriel, Reed, Ben, Fontanet, Arnaud, Rohel, Alexandra, Petrov-Sanchez, Ventzislava, Abel, Laurent, Theodorou, Ioannis, Miele, Gino, Pol, Stanislas, Albert, Matthew L.“…One relevant example is chronic hepatitis C infection, for which several treatment options are now approved. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto